ArticleScientific reports2025
Gender differences in the relationship between hearing and visual impairments, dual sensory impairment, and depression in middle-aged and elderly populations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dual Sensory Impairment and Depressive Symptoms: Association and Pathways in Three Cohorts and a Meta-Analysis.Depression and anxiety · 2026Pooled it
- Association between hearing impairment and cardiometabolic multimorbidity among middle-aged and older adults in China.Scientific reports · 2026Article
- Development and temporal validation of a prediction model for cognitive impairment in older adults with hearing loss based on the population health risk management framework.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aims to explore the association between hearing impairment, visual impairment, dual sensory impairment, and depressive symptoms in middle-aged and elderly populations in China, with an analysis of gender differences. This research is based on data from the nationally representative sample survey CHARLS, conducted from 2013 to 2020. A total of 9,780 participants were included in the study. These participants were divided into four groups based on their hearing and vision status: no impairment, hearing impairment only, visual impairment only, and dual sensory impairment. A longitudinal analysis was conducted using Cox regression models to assess the hazard ratios (HR) for the occurrence of depressive symptoms associated with hearing, visual, and dual sensory impairments. The Cox regression model indicated that, in the unadjusted model, hearing impairment, visual impairment, and dual sensory impairment were all risk factors for depression (P < 0.05). After adjusting for multiple confounding factors, compared to the no impairment group, the risk of depressive symptoms was 1.017 times higher (95% CI 0.886-1.167) in the hearing impairment group, with a gender-specific risk of 1.072 times (95% CI 0.880-1.305) for males and 0.962 times (95% CI 0.793-1.168) for females. The visual impairment group had a 1.118 times higher risk (95% CI 1.017-1.231), with a risk of 1.092 times (95% CI 0.946-1.262) for males and 1.155 times (95% CI 1.017-1.311) for females. The dual sensory impairment group had a 1.274 times higher risk (95% CI 1.165-1.393), with a gender-specific risk of 1.291 times (95% CI 1.131-1.473) for males and 1.267 times (95% CI 1.123-1.429) for females. Visual impairment and dual sensory impairment are independent risk factors for the occurrence of depressive symptoms, with notable gender differences. Understanding these associations and gender differences can help in developing more effective interventions to improve the mental health of middle-aged and elderly populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.